Correlation Between Fennec Pharmaceuticals and IQVIA Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and IQVIA Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and IQVIA Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and IQVIA Holdings, you can compare the effects of market volatilities on Fennec Pharmaceuticals and IQVIA Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of IQVIA Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and IQVIA Holdings.

Diversification Opportunities for Fennec Pharmaceuticals and IQVIA Holdings

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fennec and IQVIA is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and IQVIA Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IQVIA Holdings and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with IQVIA Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IQVIA Holdings has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and IQVIA Holdings go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and IQVIA Holdings

Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 1.39 times more return on investment than IQVIA Holdings. However, Fennec Pharmaceuticals is 1.39 times more volatile than IQVIA Holdings. It trades about 0.2 of its potential returns per unit of risk. IQVIA Holdings is currently generating about 0.09 per unit of risk. If you would invest  608.00  in Fennec Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of  58.00  from holding Fennec Pharmaceuticals or generate 9.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fennec Pharmaceuticals  vs.  IQVIA Holdings

 Performance 
       Timeline  
Fennec Pharmaceuticals 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.
IQVIA Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days IQVIA Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, IQVIA Holdings is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Fennec Pharmaceuticals and IQVIA Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fennec Pharmaceuticals and IQVIA Holdings

The main advantage of trading using opposite Fennec Pharmaceuticals and IQVIA Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, IQVIA Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IQVIA Holdings will offset losses from the drop in IQVIA Holdings' long position.
The idea behind Fennec Pharmaceuticals and IQVIA Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing